in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Big Growth in CRAMS Contracts for Jubilant
1:46 PM MDT | July 24, 2007 | Chemical Week Editorial Staff
Jubilant Organosys (Noida), one of India’s largest drug discovery and pharma services companies, says it has signed several custom research and manufacturing services (CRAMS) contracts worth a combined $60 million. The value of the deals represents a 50% increase over deals signed last year. Jubilant says that almost $54 million worth of contracts are with European and U.S. firms, and include deals with unspecified life science multinationals. “We will continue to focus on investments in innovation and world-class manufacturing facilities,” says...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee